Description: 4DMedical Limited operates as a software technology company in Australia. It commercializes XV Technology, a four-dimensional lung imaging platform that utilizes proven and patented mathematic models and algorithms to convert X-ray scans into quantitative data to enhance the capacity of physicians to manage patients with respiratory diseases and diseases of the lung. The company is also developing VQ (Perfusion), a diagnostic to scan and measure both ventilation and perfusion; and CFPA (Vasculature), a novel and non-invasive imaging technique that provides regional measurements of the pulmonary vasculature, as well as small animal ventilators and preclinical scanners. 4DMedical Limited was founded in 2012 and is based in Melbourne, Australia.
Home Page: www.4dmedical.com
4DX Technical Analysis
Melbourne Connect
Carlton,
VIC
3053
Australia
Phone:
61 3 9545 5940
Officers
| Name | Title |
|---|---|
| Dr. Andreas Fouras M.A.I.C.D., Ph.D. | Founder, MD, CTO, CEO & Exec. Director |
| Mr. John Andrew Livingston BAppSci, GradCertBus, GradDipHSc | Exec. Director |
| Mr. Simon Glover | Chief Financial Officer |
| Mr. Craige Pendleton-Browne B.Sc., M.B.A. | Chief Information Officer |
| Beth Plunkett | Company Legal Counsel |
| Mr. Clint Rodgers | VP of Marketing & Communications |
| Ms. Rachael Tenkaten | Chief of Staff |
| Mr. Paul Cooke B.A. | Sr. VP of Strategy & Bus. Devel. |
| Dr. Aidan Jamison B.E., Ph.D. | Sr. VP of Engineering |
| Dr. Michael Curtis Ph.D. | Chief Software Architect |
Exchange: AU
Country: AU
Currency: Australian Dollar (A$)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 2.0289 |
| Price-to-Sales TTM: | 107.54 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 133 |